Company Filing History:
1 out of 34 
1 out of 69 
1 out of 215 
Years Active: 2025
Title: Martine Cordier-Bussat: Innovator in Cancer Treatment
Introduction
Martine Cordier-Bussat is a notable inventor based in Chassieu, France. She has made significant contributions to the field of cancer treatment through her innovative research and development of pharmaceutical compounds. Her work focuses on mitochondrial activity inhibitors that target tumoral metabolism.
Latest Patents
Martine Cordier-Bussat holds a patent for her invention titled "Mitochondrial activity inhibitors targeting tumoral metabolism." This invention relates to compounds of formula (I), wherein specific groups and atoms are defined to create effective inhibitors for cancer treatment. The compounds are designed to be pharmaceutically acceptable salts and/or solvates, providing a promising avenue for therapeutic applications in oncology.
Career Highlights
Throughout her career, Martine has worked with prestigious institutions such as the Centre Léon Bérard and the Centre National de la Recherche Scientifique (CNRS). Her experience in these organizations has allowed her to advance her research and contribute to the scientific community significantly.
Collaborations
Martine has collaborated with esteemed colleagues, including Marc Billaud and Renaud Prudent. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in cancer treatment.
Conclusion
Martine Cordier-Bussat's contributions to cancer research through her patented inventions highlight her role as a leading innovator in the field. Her work continues to inspire advancements in therapeutic strategies for cancer treatment.